AzTrials
AzTrials

RacismNCT05902741

The Impact of a Race-Based Stress Reduction Intervention

A study testing RiSE and HEP in people with Racism and Stress, run by Loyola University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn whether a stress reduction program called Resilience, Stress, and Ethnicity (RiSE) improves well-being, inflammation, and the epigenome in African American (AA) women who have risk factors for heart or metabolic disease. Read more about this study

Who is it for?
Ages 50 to 75 years, women only
Conditions the study is for
Racism, Stress, Inflammation
What is being tested?
RiSE and HEP
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
18 Oct 2023to 31 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Between the ages of 50 and 75
  • Female
  • Post-menopausal (without menstrual period for at least 12 consecutive months)
  • Self-identified AA or Black
  • Able to write, read, speak English
  • Must have at least 1 of any of the following:
Show all 10Show fewer
  • Waist circumference >88 cm
  • Systolic BP>130 mmHg and/ or diastolic BP>88 mmHg or on antihypertensive medications
  • Diagnosed and/or being treated for hypercholesterolemia
  • History of Type 2 diabetes

Who cannot join

  • History of myocardial infarction or ischemic heart disease/angina, stent placement, coronary artery bypass, left ventricular hypertrophy, congestive heart failure, or ischemic stroke
  • Any major immune-related disease (e.g., rheumatoid arthritis. lupus)
  • Use of immune-altering medications, such as glucocorticoids
  • Periodontal disease, bleeding gums, dental work in past 72 hours
  • Current smoker or has smoked in past 3 months
  • Active cancer
Show all 9Show fewer
  • Active infection
  • Substance abuse
  • Cognitive or psychiatric disorder that would affect ability to participate in classes (Brief Screen for Cognitive Impairment total score of 8 or higher)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Karen Saban, RN, PhD contact

773-508-3990

risestudy@luc.edu

Cara Joyce, PhD contact

464-220-9521

cjoyce6@luc.edu

United States1 site, 1 recruiting
  • Loyola University Chicago

    Maywood, Illinois, 60153

    Karen Saban, RN, PhD, 708-216-1244, ksaban@luc.edu

    Karen Saban, RN, PhD

    Recruiting

Other trials in United States

About this study

Official title: The Impact of a Race-Based Stress Reduction Intervention on Well-Being, Inflammation, and DNA Methylation in African American Women at Risk for Cardiometabolic Disease

The goal of this clinical trial is to learn whether a stress reduction program called Resilience, Stress, and Ethnicity (RiSE) improves well-being, inflammation, and the epigenome in African American (AA) women who have risk factors for heart or metabolic disease.

The main question it aims to answer is whether an intervention that integrates cognitive-behavioral strategies focused on the impact that social stress, such as racism, has on the body, racial identity development, and empowerment.

Read more

Participants will placed in one of the two following groups:

  • The RiSE program will focus on teaching participants how to reduce their stress levels and will meet online weekly for approximately 2 hours each week for 8 consecutive weeks.
  • The Health Education program will include education on how to improve general health and will meet online weekly for approximately 2 hours each week for 8 consecutive weeks.

Participants will provide saliva to measure cytokines and DNA methylation (DNAm), complete questionnaires, and have blood pressure, heart rate, and weight measured at the following clinic visits:

  1. Prior to starting the intervention
  2. Mid-way through the intervention (Week 4)
  3. End of the intervention (Week 8)
  4. Six (6) months after the completion of the intervention
Read the detailed description

Participants of both programs - RiSE and Health Education Program (HEP) - will meet weekly for 8 consecutive weeks for approximately 2 hours every week. Two booster sessions will occur one month and two months after completion of the interventions. Classes will meet synchronously over Zoom. RiSE classes will be facilitated by two trained clinical psychologists. Expert speakers will be hired to provide the HEP classes (e.g dietician, pharmacist). The investigators will vary the time of day for each 8- week program in order to meet the scheduling needs of participants. Cohorts of 9-12 participants each and sessions for the treatment and control group will be provided concurrently. Topics for the health education program (HEP) (attention-control) were selected so they would not confound the overall objectives of the RiSE program.

Being tested
RiSE, HEP
Medical subject headings
Racism, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RiSEBehavioural

    RiSE provides participants with a platform to share the emotional impact of race-based stress and to offer supportive listening to their peers. Participants explicitly discuss the experiences they have as African American women, taking into account the ways which the interaction between their racial and gender identities shapes their experiences. Facilitators review difficulties associated with addressing racism and unique experiences of Black women at interpersonal and structural levels, and provide evidence of strategies to promote effective communication and internal emotional regulation regarding experiences of racism. Facilitators provide psychoeducation on intersectionality, structural racism, overt racism, microaggressions, and internalized racism. Following this education, facilitators help participants utilize cognitive-behavioral strategies to understand consequent thoughts, feelings, and actions associated with such experiences.

  • HEPBehavioural

    The HEP group will consist of classes focusing on wellness promotion. Expert speakers provide the HEP classes (e.g dietician, pharmacist).

Study groups in NCT05902741
Study groupRoleWhat they receive
Resilience, Stress, and Ethnicity (RiSE) programExperimentalResilience, Stress, and Ethnicity (RiSE) program is an 8-session weekly group-based intervention that integrates cognitive-behavioral strategies focused on the biopsychosocial impact of racism, racial identity development, and empowerment. RiSE has three primary components: 1. processing and sharing experiences related to race based stress, 2. psychoeducation on the biopsychosocial impact of racism, 3. skill building and empowerment.
Receives: Behavioral: RiSE
Health Education Program (HEP)Active comparatorHealth Education Program
Receives: Behavioral: HEP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Current perceived stress

    Perceived Stress Scale (PSS-10). Scores range from 0 to 40 with higher score suggesting worse outcome.

    Measured: 8 months

Secondary outcomes (15)
  1. General coping

    Ways of Coping Questionnaire. Scores range for 0 to 198 for total scale with higher scores suggesting more coping.

    Measured: 8 months

  2. Coping with discrimination

    Coping with Discrimination Scale. Scores range from 25 to 150 with higher scores suggesting more coping.

    Measured: 8 months

  3. Internalized racism

    Appropriated Racial Oppression Scale. Scores range from 24 to 168 with higher score suggesting worse outcome.

    Measured: 8 months

  4. Resistance and empowerment

    Resistance and Empowerment Against Racism Scale. Scores range from 26 to 130 with higher score suggesting better outcome.

    Measured: 8 months

  5. DNA methylation

    Targeted DNA methylation of targeted candidate genes

    Measured: 8 months

  6. Stress overload

    Stress Overload Scale. Scores range from 30 to 150 with higher score suggesting worse outcome.

    Measured: 8 months

  7. Depressive symptoms

    Beck Depression Inventory (BDI). Scores range from 0 to 63 with higher score suggesting worse outcome.

    Measured: 8 months

  8. Anxiety

    Generalized Anxiety Disorder-7 (GAD-7). Scores range from 0 to 21 with higher score suggesting worse outcome.

    Measured: 8 months

  9. Fatigue

    NIH Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue Short Form 8a

    Measured: 8 months

  10. Sleep disturbance

    NIH PROMIS Short Form v1.0

    Measured: 8 months

  11. Inflammatory burden- C-reactive protein (CRP)

    Salivary CRP

    Measured: 8 months

  12. Inflammatory burden - Tumor necrosis factor-alpha (TNF-alpha)

    Salivary TNF-alpha

    Measured: 8 months

  13. Inflammatory burden - Interleukin-6 (IL-6)

    Salivary IL-6

    Measured: 8 months

  14. Inflammatory burden - Interleukin-1 beta (IL-1B)

    Salivary IL-1B

    Measured: 8 months

  15. Inflammatory burden - Interferon gamma (IFN-γ),

    Salivary IFN-y

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2023
  2. Study start18 Oct 2023
  3. Primary completion31 Jan 2028 (estimated)
  4. Study completion31 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Self-identified African American women will be randomized to either the race-based stress reduction intervention group (Resilience, Stress, and Ethnicity \[RiSE\]) or the HEP.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05902741
Sponsor's protocol ID
214133
Status last verified
Aug 2026
First submitted
2 May 2023
Last updated
27 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Genomic data will be individual level data. Analysis of genomic DNA will link genotype to phenotypic information obtained as part of this study. Genomic data will include Genome wide association (GWAS) and DNA methylation (EWAS). Genomic data will be obtained from saliva taken at baseline, at completion of intervention, and 6 months after completion of intervention. The protocol, sample informed consent, case report forms, data dictionary, and code book will be made accessible in data repositories where data are shared. For data submitted to Database of Genotypes and Phenotypes (dbGaP), variable-level metadata will be provided using details of Common Data Elements, definitions, and standards used for data collection and sharing.

Publications

  • Saban KL, Joyce C, Nyembwe A, Janusek L, Tell D, de la Pena P, Motley D, Shawahin L, Prescott L, Potts-Thompson S, Taylor JY. The Effectiveness of a Race-Based Stress Reduction Intervention on Improving Stress-Related Symptoms and Inflammation in African American Women at Risk for Cardiometabolic Disease: Protocol for Recruitment and Intervention for a Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 18;14:e65649. doi: 10.2196/65649.

    PubMed 40250840
  • Taylor JY, Jones-Patten A, Prescott L, Potts-Thompson S, Joyce C, Tayo B, Saban K. The race-based stress reduction intervention (RiSE) study on African American women in NYC and Chicago: Design and methods for complex genomic analysis. PLoS One. 2024 Apr 10;19(4):e0295293. doi: 10.1371/journal.pone.0295293. eCollection 2024.

    PubMed 38598554

Questions about this trial

What is this clinical trial studying?

A study testing RiSE and HEP in people with Racism and Stress, run by Loyola University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Karen Saban, RN, PhD (773-508-3990, risestudy@luc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Current perceived stress (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05902741, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in